MeSH term
Frequency | Condition_Probility | Adult | 15 | 0.0 |
Aged | 11 | 0.0 |
Base Sequence | 6 | 0.0 |
Cerebral Infarction/*genetics | 3 | 37.0 |
DNA Mutational Analysis | 7 | 0.0 |
Dementia, Multi-Infarct/*genetics | 9 | 90.0 |
English Abstract | 7 | 0.0 |
Exons/genetics | 4 | 0.0 |
Female | 20 | 0.0 |
Genes, Dominant | 3 | 0.0 |
Humans | 59 | 0.0 |
Male | 21 | 0.0 |
Middle Aged | 20 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
*Mutation, Missense | 4 | 0.0 |
Pedigree | 7 | 0.0 |
Point Mutation/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 16 | 1.0 |
Receptors, Cell Surface/*genetics | 4 | 1.0 |
Animals | 24 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
Ligands | 7 | 0.0 |
Mice | 20 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
*Transcription Factors | 11 | 0.0 |
Magnetic Resonance Imaging | 13 | 1.0 |
Phenotype | 5 | 0.0 |
Proto-Oncogene Proteins/genetics | 8 | 1.0 |
*Receptors, Cell Surface | 33 | 8.0 |
Child | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Homeodomain Proteins/genetics | 3 | 1.0 |
Membrane Proteins/genetics/metabolism | 2 | 1.0 |
Mice, Transgenic | 4 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 4 | 1.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Comparative Study | 8 | 0.0 |
Receptors, Cell Surface/genetics/*physiology | 2 | 3.0 |
Signal Transduction | 5 | 0.0 |
Transfection | 2 | 0.0 |
Chromosome Aberrations | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
Signal Transduction/genetics | 3 | 1.0 |
Blood Flow Velocity | 2 | 2.0 |
Time Factors | 2 | 0.0 |
*Ultrasonography, Doppler, Transcranial | 2 | 50.0 |
Sensitivity and Specificity | 4 | 0.0 |
Skin/pathology | 3 | 1.0 |
Cells, Cultured | 4 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 3 | 2.0 |
*Signal Transduction | 4 | 0.0 |
Brain/pathology | 5 | 1.0 |
Exons | 4 | 0.0 |
*Mutation | 6 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Alleles | 3 | 0.0 |
Mutation | 14 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Cysteine/genetics | 2 | 1.0 |
Family Health | 4 | 0.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
In Situ Hybridization | 6 | 0.0 |
Dementia, Multi-Infarct/*diagnosis/genetics | 2 | 100.0 |
Genotype | 3 | 0.0 |
Risk Factors | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Adolescent | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Age of Onset | 4 | 0.0 |
Models, Genetic | 3 | 0.0 |
*Genes, Dominant | 2 | 0.0 |
Muscle, Smooth, Vascular/metabolism | 2 | 3.0 |
Point Mutation/*genetics | 2 | 0.0 |
Japan/epidemiology | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Cell Division/genetics | 2 | 0.0 |
Epidermal Growth Factor/genetics | 3 | 4.0 |
Linkage (Genetics) | 2 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Arginine/genetics | 2 | 1.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Cell Count | 2 | 0.0 |
*Cell Differentiation | 3 | 1.0 |
Epithelial Cells/*cytology/metabolism | 2 | 12.0 |
Chromosomes, Human, Pair 19/*genetics | 2 | 2.0 |
Karyotyping | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Receptors, Cell Surface/genetics/*metabolism | 2 | 1.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Up-Regulation | 3 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Gene Expression | 2 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
Repressor Proteins/biosynthesis | 2 | 14.0 |
Cerebral Arterial Diseases/*genetics | 2 | 100.0 |
Proteins/genetics | 3 | 0.0 |
Rats | 4 | 0.0 |
Cell Lineage | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Chromosomes, Human, Pair 19 | 2 | 1.0 |
Receptors, Cell Surface/biosynthesis | 2 | 5.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
